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Previously, we have demonstrated that hepatitis B virus (HBV) core particles tolerate the insertion of the amino-terminal 120 amino acids
(aa) of the Puumala hantavirus nucleocapsid (N) protein. Here, we demonstrate that the insertion of 120 amino-terminal aa of N proteins from
highly virulent Dobrava and Hantaan hantaviruses allows the formation of chimeric core particles. These particles expose the inserted foreign
protein segments, at least in part, on their surface. Analysis by electron cryomicroscopy of chimeric particles harbouring the Puumala virus
(PUUV) N segment revealed 90% T = 3 and 10% T = 4 shells. A map computed from T = 3 shells shows additional density splaying out from
the tips of the spikes producing the effect of an extra shell of density at an outer radius compared with wild-type shells. The inserted Puumala
virus N protein segment is flexibly linked to the core spikes and only partially icosahedrally ordered. Immunisation of mice of two different
haplotypes (BALB/c and C57BL/6) with chimeric core particles induces a high-titered and highly cross-reactive N-specific antibody response
in both mice strains.
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Introduction bling those in HBV-infected liver cells (Cohen and Rich-Non-infectious virus-like particles (VLPs) can be gener-
ated by heterologous expression of viral structural proteins
and their spontaneous self-assembly (for review, see
Pumpens and Grens, 2003). The core protein of hepatitis
B virus (HBV) expressed in bacteria forms shells resem-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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Avenue, New York, NY 10027-7556, USA.mond, 1982). E. coli-expressed core has been demonstrated
to assemble icosahedral shells with 180 (T = 3) or 240 (T =
4) subunits (Crowther et al., 1994). Due to its advantageous
features, HBV core has been extensively exploited as a
carrier for foreign epitopes (for reviews, see Pumpens and
Grens, 2001; Ulrich et al., 1998a). Most importantly, core
particles have been demonstrated to drastically improve the
immunogenicity of foreign protein segments presented on
their surface (Clarke et al., 1987; Francis et al., 1990).
Moreover, on the basis of HBV core, highly promising
vaccine candidates have been generated for influenza (Neir-
ynck et al., 1999) and malaria (Sa¨llberg et al., 2002).
Fig. 1. Detection of purified entire HBc and carboxy-terminally truncated
HBcd and HBcd fusions with DOBV, HTNV, or PUUV N segments in
stained SDS-PAGE (A) and immunoblot using rabbit anti-HBc (B) and
mouse anti-DOBV-Slo rN antibodies (C). Gel chromatography-purified, E.
coli-expressed entire core (HBc), carboxy-terminally truncated core
(HBcd), and HBcd fusions carrying 120 amino-terminal amino acids of
the nucleocapsid protein of the hantaviruses Dobrava (HBcdDOB120),
Hantaan (HBcdHTN120), and Puumala (HBcdPUU120) were subjected to
a 12.5% SDS-PAGE. As a negative control protein for the anti-HBc
Western Blot, yeast-expressed recombinant nucleocapsid protein of the
Dobrava hantavirus was included (DOBV rN).
A. Geldmacher et al. / Virology 323 (2004) 108–119 109In general, two strategies to generate HBV core-derived
particles presenting foreign epitopes have been developed:
(i) one can generate authentic HBV core particles and link
foreign epitopes chemically (Jegerlehner et al., 2002). (ii)
Fusion of foreign epitopes to the core protein can be
facilitated by genetic engineering. This may generate chi-
meric core particles consisting of identical fusion protein
subunits or alternatively mosaic particles consisting of the
core carrier itself and a core-fusion subunit. Mosaic particles
have been generated in two different ways, by a suppressor-
mediated readthrough of a stop codon located between the
coding information of HBV core and the foreign insert
(Kazaks et al., 2002; Koletzki et al., 1997) or by co-
expression of core and the core fusion protein from differ-
ent, compatible plasmids in the same E. coli cell (Preikschat
et al., 2000).
In previous experiments, three potential insertion sites for
foreign protein segments into HBV core have been used: the
amino-terminus, the internal major immunodominant region
(MIR), and different carboxy-terminal positions (for
reviews, see Pumpens and Grens, 2001; Ulrich et al.,
1998a). According to the three-dimensional structure
(Bo¨ttcher et al., 1997; Wynne et al., 1999), epitope mapping
data (Salfeld et al., 1989) and empirical insertion data, the
MIR represents the most preferential insertion site for
foreign sequences (Borisova et al., 1996; Lachmann et al.,
1999; Scho¨del et al., 1992).
Hantaviruses can cause two different diseases in humans:
haemorrhagic fever with renal syndrome (HFRS) with a
case fatality index of up to 15% and hantavirus cardiopul-
monary syndrome (HCPS) with a case fatality index of up to
40% (for reviews, see Kru¨ger et al., 2001; Schmaljohn and
Hjelle, 1997; Ulrich et al., 2002). Human infections with the
prototype hantavirus, Hantaan virus (HTNV), carried by the
striped field mouse in Asia, resulted in severe courses of
HFRS (Lee et al., 1978). In Europe, mainly two hantavi-
ruses have been found to cause HFRS of different severity
in humans (Mustonen et al., 1998; Plyusnin et al., 2001;
Sibold et al., 1999). Puumala virus (PUUV) carried by the
bank vole Clethrionomys glareolus is known to cause the
Nephropathia epidemica, a mild form of HFRS (Brummer-
Korvenkontio et al., 1982). In Southeast Europe, Dobrava
virus (DOBV) carried by the yellow-necked mouse Apode-
mus flavicollis (DOBV-Af) is responsible for clinically
severe HFRS cases (Avsic-Zupanc et al., 1995; Papa et
al., 2001). Recently, DOBV-Af-like strains (Saaremaa and
DOBV-Aa) have been found in the striped field mouse A.
agrarius (Klempa et al., 2003; Nemirov et al., 1999; Sibold
et al., 2001). It has been proposed that mild clinical courses
of DOBV infections in Central and East Europe might be
due to infections by those virus strains (Golovljova et al.,
2002; Plyusnin et al., 2001; Schu¨tt et al., 2001; Ulrich et al.,
2002).
Potential vaccines against PUUV and DOBV have been
generated by E. coli-, yeast-, and baculovirus-mediated
expression of the nucleocapsid (N) protein (Dargeviciuteet al., 2002; de Carvalho Nicacio et al., 2002; Lundkvist et
al., 1996). We have previously demonstrated that HBV core
particles tolerate the insertion of 45- and 120-amino-acid
(aa)-long amino-terminal segments of PUUV N protein into
core (Koletzki et al., 1999, 2000). Moreover, chimeric core
particles are able to induce a strong protective immune
response in bank voles (Koletzki et al., 2000; Ulrich et al.,
1998b). Although the precise mechanism of N protein-
mediated protective immunity is not well understood, both
the cellular and humoral arm of immune response seem to
be involved, at least in animal models (for refs., see de
Carvalho Nicacio et al., 2002; Lundkvist et al., 2002).
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core particles harbouring an 120-aa-long PUUV N segment
by electron cryomicroscopy. We demonstrate that core also
tolerates the insertion of N protein segments of the highly
virulent DOBV and HTNV hantaviruses. Moreover, we
present evidence that chimeric HBV core particles harbour-
ing the amino-terminal segment of N protein from DOBV,
HTNV, or PUUV induce a high-titered and cross-reactive N-
specific antibody response in mouse strains of two different
haplotypes.Results
Insertion of 120 amino-terminal aa of N proteins from
DOBVor HTNV into MIR of HBV core allows the formation
of chimeric HBV core particles
HBV core fusion proteins were generated in E. coli by
insertion of the 120 amino-terminal aa of N proteins from
DOBV (strain Slovenia, DOB120), HTNV (strain Fojnica,
HTN120), or PUUV (strain Vranica/Ha¨llna¨s, PUU120) into
the MIR of a carboxy-terminally truncated HBV core
(HBcd, expression plasmid pHBc2-19d). According to their
molecular masses, the fusion proteins HBcdDOB120 (31.5
kDa) and HBcdHTN120 (31.8 kDa; Fig. 1A, lanes 3, 4))
migrated in Coomassie blue-stained SDS-PAGE slower than
HBcd alone (17.8 kDa; Fig. 1A, lane 2). In contrast to its
predicted molecular mass (31.8 kDa), the HBcdPUU120
fusion protein migrated slightly slower (Fig. 1A, lane 5)
than the DOBV and HTNV constructs. The expected core
fusion protein bands were detected in Western blots with
polyclonal rabbit serum raised against core and mouse
serum raised against yeast-expressed recombinant N (rN)Fig. 2. Detection of core particle formation by negative staining electron microsco
carrying 120 amino acids of N protein of the hantaviruses Hantaan (HBcdHTN12
negatively stained. Scale bar, 100 nm.protein of DOBV strain Slovenia (DOBV-Slo; Figs. 1B and
C, lanes 3–5). As expected, yeast-expressed rN protein of
DOBV-Slo used as a control was detected by the N-specific
mouse serum (Fig. 1C, lane 6), but not by anti-core anti-
bodies (Fig. 1B, lane 6).
Both HTNV and DOBV fusion proteins reacted with N-
specific, cross-reactive monoclonal antibodies (mAbs)
raised against PUUV (1C12, 4C3, 5A3; Lundkvist and
Niklasson, 1992; Lundkvist et al., 1991) and HTNV (E5/
G6; Yoshimatsu et al., 1996). In line with previous data
(Lundkvist et al., 2002), mAb 5A3 did not react with the
PUUV-Vranica/Ha¨llna¨s construct. As expected, the mAb
Eco2 (Yoshimatsu et al., 1996) was found to react with
HTNV and DOBV constructs, but not with the PUUV
construct. In contrast, the HTNV- and PUUV-specific mAbs
B5D9 and A1C5 (Zo¨ller et al., 1993) detected only the
corresponding homologous antigens (data not shown).
The formation of chimeric core particles harbouring
HTNV, DOBV, or PUUV inserts was confirmed by negative
staining electron microscopy (Figs. 2B–D). Moreover,
immune electron microscopy using the N-specific mAb
4C3 suggested the surface exposure of the foreign sequence
on the three different chimeric core-like particles formed by
HBcdHTN120, HBcdDOB120, and HBcdPUU120 (data not
shown). The carboxy-terminally truncated core itself formed
particles which did not react with the mAb 4C3 (Fig. 2A and
data not shown).
Chimeric HBcd particles are contaminated with endotoxins
and small amounts of nucleic acid
To analyse the nucleic acid contamination of core par-
ticles, an agarose gel electrophoresis was performed. Coo-
massie blue staining revealed the presence of approximatelypy. Purified HBcd without any insert (A) and purified HBcd fusion proteins
0, B), Dobrava (HBcdDOB120, C), and Puumala (HBcdPUU120, D) were
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expected, entire core (HBc, aa 1–183) used as a control was
found in the ethidium bromide-stained agarose gel to contain
large amounts of nucleic acid contamination (Fig. 3B, lane 1).
In contrast, carboxy-terminally truncated HBcd (Fig. 3B, lane
2) and its fusion variants with hantavirus N, HBcdDOB120
(lane 3), HBcdHTN120 (lane 4), and HBcdPUU120 (lane 5),
contained only very small traces of nucleic acids. This
difference in the amount of nucleic acid contamination of
core particles was confirmed by determination of the ratio of
absorption at 260 and 280 nm (Fig. 3C).
Investigation of the endotoxin contamination of the core
particles revealed an interesting difference between those
formed by HBcd (512 EU/mg protein) and HBcd fusionsFig. 3. Detection of nucleic acid contamination in core particles by agarose
gel electrophoresis and analysis of the ratios of the absorption at 260 and 280
nm. A 1% agarose gel was loaded with 5 Ag of purified, carboxy-terminally
truncated HBcd (pHBc2-19d, lane 2) or equimolar amounts of full-length
hepatitis B virus core (HBc, lane 1) or HBcd-based constructs with 120 aa of
N proteins from hantaviruses Dobrava (HBcdDOB120, lane 3), Hantaan
(HBcdHTN120, lane 4), or Puumala (HBcdPUU120, lane 5) and stainedwith
Coomassie blue (A) or ethidium bromide (B). The OD260 nm to OD280 nm
wavelength ratio (C) represents the ratio of the amount of nucleic acid (260
nm) to the amount of protein (280 nm). It was estimated by measurement of
the proteins mentioned above at a concentration of 10 Ag/ml. The arrowheads
in B localise the place of potential nucleic acid contamination of HBcd and
the corresponding HBcd fusions. LaneM (A,B): Gene ruler DNA ladder mix
(Fermentas, Vilnius, Lithuania, Catalogue no. SM0333).with N segments of DOBV (6560 EU/mg) and PUUV (4740
EU/mg; data not shown).
Electron cryomicroscopic investigations demonstrate
surface exposure and flexibility of the major protective
region of PUUV nucleocapsid protein on HBV core
Previously, we have demonstrated by ELISA and im-
mune electron-microscopic investigations that HBcPUU120
particles expose the foreign sequence, at least in part, on
their surface (Koletzki et al., 1999). In contrast to the
abovementioned protein HBcdPUU120, the HBcPUU120
fusion protein contains an additional pentapeptide originated
from the preS1 region of HBV (sequence DPAFR).
To elucidate the structural features of the chimeric
HBcPUU120 particles in more detail, electron cryomicro-
scopy was performed which potentially provides a more
sensitive way, compared with negative staining, of visual-
izing shells with inserts. Images of shells without inserts
display a clear sharp outline and the preparation shown in
Fig. 4A consists predominantly of T = 3 particles. A map
computed from such a preparation (Fig. 4C) shows 90 dimer
spikes sticking out from a fenestrated spherical shell
(Crowther et al., 1994). Images of shells with the PUUV
N protein insert show a much fuzzier outline with additional
material around the periphery (Fig. 4B). This preparation of
shells contained approximately 90% T = 3 shells and 10% T =
4 shells. A map computed from a set of T = 3 shells with
inserts (Fig. 4D) shows additional density splaying out from
the tips of the spikes producing the effect of an extra shell of
density at an outer radius. This extra shell can be clearly
seen when the map of the particle is sliced in half and
viewed from the cut surface (Fig. 4E). The diameter of the
particle without inserts is about 32 nm but this is increased
to about 36 nm for the particle with inserts. The inner parts
of the spikes and the spherical shell are closely similar
between the two maps. However, it is clear that the
additional material in the map with inserts does not obey
the local T = 3 symmetry. This is demonstrated, for example,
by fact that the six dimer spikes around a 3-fold axis in the
map without inserts (Fig. 4C) form a regular hexagon,
whereas the inserted material (Fig. 4D) leaves markedly
triangular holes at the 3-fold axes.
Chimeric HBV core particles induce a high-titered and
highly cross-reactive N-specific antibody response in
BALB/c and C57BL/6 mice
Chimeric core particles formed by HBcdDOB120,
HBcdHTN120, and HBcdPUU120 induced high-titered N-
specific antibody responses in both BALB/c (Fig. 5A) and
C57BL/6 mice (Fig. 5C). In both mouse strains, the highest
homologous titers were observed against PUUV N
(1:300000 and 1:40000), whereas the titers of HTNV N-
specific were half and DOBV N-specific antibodies one
order of magnitude lower. Serum pools of mice immunised
Fig. 4. Electron cryomicroscopy of hepatitis B core shells with and without hantavirus inserts. (A) Core shells without insert formed by a carboxy-terminally
truncated core (aa 1–144, expressed from plasmid pHBc2-19), predominantly of T = 3 type. (B) Core shells with hantavirus PUUV insert formed by
HBcPUU120. Note the additional material around the outside of the shells compared with those in A. (C) Computed map viewed down on a 2-fold axis of the
T = 3 shell without insert, showing dimer clustered spikes. (D) Computed map of the T = 3 core shell with hantavirus insert, viewed in the same orientation as C.
Note the additional density splaying out from the tips of the spikes. (E) The same map as in D but with the front half removed. The equatorial cut surface passes
through various surface spikes, which have the same shape as those in C at inner radii but show the additional density splaying out from the tips. Scale bar in A
(for A and B), 50 nm.
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the ELISA (data not shown).
Sera of mice immunised with HBcdDOB120,
HBcdHTN120, and HBcdPUU120 are all reactive to the
heterologous rN proteins of DOBV, HTNV, and PUUV
when tested in ELISA (Figs. 5B, D). Although in general
the heterologous titers in BALB/c mice (Fig. 5B) were
higher than in C57BL/6 mice (Fig. 5D), the pattern of
cross-reactivity did not differ between mice of the two
strains. Sera of mice immunised with HBcdDOB120 and
HBcdHTN120 were highly cross-reactive to the heterolo-
gous rN proteins of the more closely related HTNV and
DOBV strains Slovenia (DOBV-Slo) and Slovakia (DOBV-
Slk), respectively, but showed a weaker reactivity to the rN
protein of the more distantly related PUUV strains. Com-
parably, the sera of mice immunised with HBcdPUU120
reacted strongly to the rN proteins of all three PUUV strains
but showed a weaker reactivity to the rN proteins of DOBV-
Slo, DOBV-Slk, and HTNV.
Interestingly, the level of cross-reactivity was lower
when sera were tested in Western Blot. Sera of mice
immunised with HBcdDOB120 reacted to a low extent to
rN proteins of PUUV strains Kazan (PUUV-Kaz) and
Sotkamo (PUUV-Sot) and did not react at all to rN protein
of PUUV strain Vranica/Ha¨llna¨s (PUUV-Vra) (data not
shown). The same was observed for sera of mice immunised
with HBcdHTN120. The sera of mice immunised withHBcdPUU120 reacted exclusively to PUUV rN protein,
but not to rN proteins of DOBVor HTNV (data not shown).Discussion
HBV core tolerates the insertion of large-sized foreign
protein segments
During recent years, different VLP carrier systems have
been developed. For the generation of chimeric VLPs as
potential vaccines, the insertion capacity of the carrier is a
critical issue. Carriers like bacteriophage coat proteins have
been found to have a very limited insertion capacity (Pushko
et al., 1993; Voronkova et al., 2002). In contrast, bluetongue
virus NS1 tubules, parvovirus B19- and yeast retrotranspo-
son Ty-derived VLPs have been found to tolerate extended
insertions of up to 100–200 foreign aa (Adams et al., 1987;
Mikhailov et al., 1996; Miyamura et al., 1994).
The insertion capacity of HBV core is dependent on the
insertion site used (for review, see Ulrich et al., 1998a).
Although the carboxy-terminus of HBV core was found to
tolerate extended foreign fusions (Ulrich et al., 1992; Yoshi-
kawa et al., 1993), the MIR has become the most widely used
insertion site because of the surface exposure and the
resulting high immunogenicity of the foreign insertions
(Scho¨del et al., 1992; see reviews in Pumpens and Grens,
Fig. 5. Analysis of the homologous (A, C) and cross-reactive antibody responses (B, D) induced by chimeric core particles in BALB/c (A, B) and C57BL/6
mice (C, D). BALB/c and C57BL/6 mice were immunised with 20 Ag protein (HBcdDOB120, HBcdHTN120, or HBcdPUU120) with complete Freund’s
adjuvant at day 0, with 10 Ag of proteins with incomplete Freund’s adjuvant (IFA) at day 10, and 20 Ag protein with IFA at day 19. Blood was taken at day 28
and endpoint titers (three times the background) were determined by ELISAwith rN proteins of the hantaviruses DOBV, strain Slovenia (DOBV-Slo) and strain
Slovakia (DOBV-Slk), Hantaan virus, strain Fojnica (HTNV-Foj), and Puumala virus strains Vranica/Ha¨llna¨s (PUUV-Vra), Kazan (PUUV-Kaz) and Sotkamo
(PUUV-Sot). Shown are the mean reciprocal log10 endpoint titers and standard deviations of four BALB/c and three C57BL/6 mice.
A. Geldmacher et al. / Virology 323 (2004) 108–119 1132001; Ulrich et al., 1998a). Previously, we have demonstrat-
ed that HBV core tolerates the insertion of 120 aa derived
from the N protein of PUUV (Koletzki et al., 1999). This
high insertion capacity of HBV core is here confirmed by the
formation of core particles carrying 120 aa of HTNV or
DOBV N proteins. Moreover, the additional presence or
absence of a DPAFR sequence insertion at the MIR seems
not to influence the particle formation ability of core as
evidenced for 120 amino-terminal aa of PUUV N protein
(Koletzki et al., 1999; this paper). Furthermore, core even
tolerates the simultaneous insertion of two 120-aa-long seg-
ments originating from HTNV and PUUV N proteins with-
out abolishing the self-assembly of core (our unpublished
data) which is in line with previous data about core/green
fluorescent protein fusions reported by Kratz et al. (1999).
Endotoxin and nucleic acid contamination are potential
disadvantages of E. coli-expressed chimeric HBV core
particles
In contrast to the absence of E. coli endotoxins in yeast-
expressed rN protein of PUUV-Vra (Razanskiene et al.,
submitted for publication), we detected endotoxins in the
core particle preparations with or without foreign hantavirusinsertion. However, the endotoxin contamination of chime-
ric core particles was 8- to 10-fold higher than in authentic
HBcd. Usually, the endotoxin contamination of entire HBc
is reproducible in the range of 3000–10000 EU/mg
(Renhofa and Petrovskis, unpublished data). The reason
for the lower level of endotoxin content of truncated HBcd
compared to entire HBc is unknown and requires further
investigations. This endotoxin contamination might repre-
sent a potential disadvantage of E. coli-expressed core
which, however, might be overcome by optimisation of
the purification procedure by including dissociation/reasso-
ciation steps (Wizemann and von Brunn, 1999) or alterna-
tively by use of a yeast expression as reported by others
(Beesley et al., 1990).
In line with previous data for carboxy-terminally trun-
cated core (Birnbaum and Nassal, 1990) and chimeric core
particles (Ulrich et al., 1993), we detected only traces of
nucleic acid contamination in chimeric core particles har-
bouring hantavirus insertions. This low level of nucleic acid
contamination is due to the lack of the nucleic acid-binding
domain located at the carboxy-terminus of core (Gallina et
al., 1989). As previous data confirmed, the presence of E.
coli-specific RNA in the particle preparations might be not
important in terms of vaccine development.
irology 323 (2004) 108–119HBV core particles present foreign sequences inserted into
the MIR on the surface of particles
The most important issue for vaccine development is the
structure of core particles, that is, the surface exposure of the
inserted foreign sequence, and the resulting B cell immu-
nogenicity. Previously, we have demonstrated the surface
exposure of the amino-terminal segment of PUUV-Vra N on
DPAFR-containing core particles by immuno-electron mi-
croscopy and ELISA (Koletzki et al., 1999). In line with
these data, we detected by immuno-electron microscopy an
at least partial surface exposure of the DOBV, HTNV, and
PUUV N segments on the corresponding chimeric core
particles lacking the DPAFR sequence.
We observed by electron cryomicroscopy of the
HBcPUU120 preparation a majority of T = 3 shells (90%)
and only a minority of T = 4 shells. This represents
considerably more of a bias towards T = 3 particles than
would be expected for a core protein truncated at position
144 (Zlotnick et al., 1996), so the insert appears to be
influencing the size of the shells. The three-dimensional
map of T = 3 shells showed additional density splaying out
from the tips of the spikes producing the effect of an extra
shell of density. The additional material in the map with
PUU120 insert does not obey the T = 3 symmetry. This
suggests that the inserted PUUV N protein segment is
flexibly linked to the core spikes and only partially icosahe-
drally ordered, as has been observed with a similarly
inserted green fluorescent protein domain (Kratz et al.,
1999). The structural behaviour of the insert on the surface
of core may also explain the previously observed lower HBc
antigenicity of chimeric HBcPUU120 particles which was
suggested to be due to masking of the major core epitope
(Koletzki et al., 1999).
Chimeric HBV core particles induce a strong and
cross-reactive antibody response against N protein in mice
of two different haplotypes
Immunisation of two different mice strains (BALB/c and
C57BL/6) with chimeric core particles resulted in the
induction of antibodies highly reactive with the
corresponding homologous antigens. The endpoint titers
observed in BALB/c mice were slightly higher than those
in C57BL/6 mice. In general, the strong immunogenicity of
the chimeric core particles harbouring 120 amino-terminal
aa of the hantavirus N proteins generates similar titers of N-
specific antibodies to those observed by immunisation of
mice, bank voles, and rabbits with entire rN proteins of
different hantaviruses (de Carvalho Nicacio et al., 2001,
2002; Razanskiene et al., submitted for publication). This is
in line with the amino-terminus representing an immunodo-
minant region of N protein (Elgh et al., 1996; Go¨tt et al.,
1997; Jenison et al., 1994; Lundkvist et al., 1996). How-
ever, the titers were lower than those observed in mice
immunised with entire yeast-expressed rN protein of
A. Geldmacher et al. / V114DOBV-Slo (Geldmacher et al., 2004). These lower titers
might be explained by the presence of additional, more
carboxy-terminally located epitopes in N protein (Lundkvist
et al., 1996, 2002).
As previously observed for entire E. coli- (de Carvalho
Nicacio et al., 2002) and yeast-expressed rN proteins
(Geldmacher et al., 2004) of different hantaviruses, immu-
nisation of mice with chimeric core particles resulted in a
highly cross-reactive antibody response. This confirms
again previous data about a highly cross-reactive region
located at the amino-terminus of N protein (Elgh et al.,
1998). This cross-reactivity is also confirmed by binding of
mAbs, directed against the amino-terminal region of N, to
heterologous N proteins (Dzagurova et al., 1995; Razan-
skiene et al., submitted for publication; this paper; Yoshi-
matsu et al., 1996).
In conclusion, insertion of 120-aa-long segments of N
proteins from highly virulent HTNV and DOBV confirmed
the high insertion capacity of core at the MIR. Electron
cryomicroscopy analysis of core particles harbouring 120 aa
of PUUV N protein showed the surface exposure of the
foreign sequence. The observed contamination of core
particles with endotoxins represents a potential disadvan-
tage, but might be prevented by using other purification
procedures or a yeast expression system. Immunisation of
mice of two different haplotypes with chimeric core par-
ticles resulted in the induction of a high-titered N-specific
antibody response. The response against the corresponding
homologous antigen was higher than against the
corresponding heterologous N proteins. The core particles
described here are interesting vaccine candidates which
should be characterised in terms of induction of a protective
immunity.Materials and methods
Expression plasmids
For cloning of the N protein-encoding sequences of
PUUV, HTNV, and DOBV, we modified the expression
plasmid pHBc2-19 encoding a carboxy-terminally truncated
HBV core (aa 1–144; Borisova et al., 1996) by deleting its
DPAFR-encoding sequence (Shamil Musema, 1998). The
resulting plasmid pHBc1-78/X/78-144 (Lundkvist et al.,
2002) encoding a carboxy-terminally truncated HBV core
without DPAFR insertion (HBcd) was here redesignated as
pHBc2-19d.
The PCR amplification and cloning of the sequence
encoding the 120 amino-terminal aa of PUUV (strain Vran-
ica/Ha¨llna¨s; Reip et al., 1995) N protein in plasmid pHBc2-
19 have been described previously (Koletzki et al., 1999;
pHBcPUU120). The same sequence was isolated as a
BamHI–BglII fragment and inserted into BamHI-linearised
plasmid pHBc2-19d. The resulting plasmid pHBcdPUU120
contains a unique BamHI site allowing additional insertions
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already published plasmid (Koletzki et al., 1999) used here
for electron cryomicroscopy analysis, this new construct did
not contain the DPAFR epitope-encoding sequence.
The sequence coding for the 120 amino-terminal aa of N
protein from HTNV (strain Fojnica; Sibold et al., 1999) was
PCR amplified from the template pTA-FoS, kindly provided
by Angela Schulz, using the primers HTN-N (5V-AAA GAT
CTA ATG GCA ACT ATG GAG GAA TTA CAG) and
HTN-C120 (5V-ATA GAT CTC TCA GCC AGT CTG CTG
TCT GTC CTG T), cloned into plasmid pCR2.1 (Invitro-
gen), and re-sequenced. The authentic sequence was isolat-
ed as a BglII fragment and inserted into BamHI-linearised
plasmid pHBc2-19d (pHBcdHTN120). Similarly, the se-
quence coding for the 120 amino-terminal aa of N protein
from DOBV (strain Slovenia DOBV-Slo; Avsic-Zupanc et
al., 1995) was PCR-amplified, cloned, and sequenced. The
authentic sequence was isolated as a BamHI–BglII fragment
and inserted into BamHI-linearised plasmid pHBc2-19d
(pHBcdDOB120).
Expression and purification of chimeric core particles
For electron cryomicroscopy, authentic and chimeric
core particles expressed from plasmids pHBc2-19 and
pHBcPUU120 were purified by sucrose gradient centrifu-
gation as described previously (Koletzki et al., 1999). The
other core and chimeric HBV core proteins (HBcd,
HBcdPUU120, HBcdHTN120, HBcdDOB120) were
expressed in E. coli strain K802 according to a protocol
described previously (Borisova et al., 1993). Cells were
sedimented and lysed by 30 min incubation on ice in lysis
buffer (50 mM Tris–HCl, pH 8.0; 5 mM EDTA; 0.3 mM
PMSF; 1 mg/ml lysozyme) and then ultrasonicated three
times (15 s, 22 kHz). The lysates were adjusted to 10 mM
MgCl2 and 20 Ag/ml DNase, urea was added to a final
concentration of 0.15 M, and lysates were extracted by
gentle stirring at 4 jC for 30 min.
After extraction, the lysates containing HBcd or
HBcdDOB120 were cleared by centrifugation and proteins
were precipitated from the supernatant with 33% ammoni-
um sulphate for 1–3 h at 4 jC. Pellets were resuspended in
PB (PBS without NaCl and KCl) containing 0.1% Triton X-
100 (PB/Triton), loaded on a Sepharose CL4B column (2.5
 85 cm), and eluted with PB buffer. Fractions containing
the core protein derivatives were pooled and precipitated
again with 33% ammonium sulphate for 20 h at 4 jC.
Pellets were resuspended in PB or Tris–saline buffer (10
mM Tris–HCl, pH 7.5; 150 mM NaCl) to a final concen-
tration of 5–20 mg/ml, dialysed overnight against 2000
volumes of the same buffer, and stored at 20 jC in 50%
glycerol.
After extraction, the lysates containing HBcdHTN120 or
HBcdPUU120, respectively, were cleared by centrifugation.
HBcdHTN120 was in the supernatant of which bulk protein
was removed by precipitating it with 20% ammonium sul-phate for 1 h at 4 jC, following centrifugation (10000 rpm,
10 min, 4 jC). In contrast to HBcdHTN120, HBcdPUU120
remained in the sediment and had to be extracted again with
0.45 M urea in PB to bring it into the supernatant. Both
proteins were then precipitated with 30% ammonium sul-
phate for 3 h at 4jC and centrifuged at 15000 g for 20 min
at 4 jC. Pellets were resuspended in PB/Triton and loaded on
a discontinuous sucrose gradient in PB (20–50%). After
centrifugation at 28000 rpm for 22 h at 4 jC (Beckman L7-
55, rotor SW28), fractions of 1.5 ml were collected and
subjected to SDS-PAGE andWestern blot analysis. Fractions
containing the HBc proteins were pooled, precipitated for 20
h at 4 jCwith 33% ammonium sulphate, and NaCl was added
to a final concentration of 150 mM. Pellets were resuspended
in PBS to a final concentration of 5–20 mg/ml and stored at
20 jC in 50% glycerol.
Nucleic acid contamination
Nucleic acid contamination of HBc (aa 1–183) and
HBcd derivatives (aa 1–144) were determined by gel
electrophoresis in 1% agarose gels of equimolar amounts
of the different purified core particles corresponding to 5 Ag
of HBcd and by determination of the ratio of the absorption
at 260 and 280 nm of purified HBV core derivatives at a
concentration of 10 Ag/ml.
Electron microscopy and immuno-labelling
Control core particles without insert (HBcd) and the three
core preparations containing the 120-aa inserts derived from
the three hantavirus strains (HBcdHTN120, HBcdDOB120,
HBcdPUU120) were negatively stained using 1% uranyl
acetate as described earlier (Gelderblom et al., 1967). To
detect the insertions immunologically, core samples were
diluted to 100 Ag/ml in PBS and adsorbed onto hydrophilic
carbon and Pioloform-coated copper grids. The grids with
adhering cores were washed for 30 s on a droplet of
‘‘conditioning’’ buffer (PBS containing 0.1% BSA) and
transferred for immune decoration for 30 min onto droplets
of the purified mAb 4C3 at concentrations of 60 and 6 pg/Al.
Non-bound antibody was removed by washing the grids on
two droplets of buffer followed by four droplets of distilled
water and negatively stained as above.
Electron cryomicroscopy
Sample preparation
Samples were frozen as described (Dubochet et al.,
1988). Four microliters of core suspension at about 4 mg/
ml were applied to a holey carbon film on a copper grid
mounted in a modified controlled environment freezing
apparatus (Bellare et al., 1988). The samples were blotted
with filter paper (Whatman no.1, Whatman International
Ltd., Maidstone, England) for 3–5 s before plunging into
liquid ethane. For cryomicroscopy, a Hitachi HF2000 mi-
A. Geldmacher et al. / Virolog116croscope equipped with a field emission gun and Gatan cold
stage was used. Micrographs were taken at a nominal
magnification of 60000 with a beam diameter of 1.3–
1.5 Am, defocus between 1.5 and 2.6 Am, and exposure
times of between 1.5 and 2 s on Kodak SO163 film. The
electron dose was between 10 and 16 e/A2.
Image processing
Micrographs were checked by optical diffraction for
absence of astigmatism and scanned with a Zeiss SCAI
scanner using a step size of 14 Am per pixel, corresponding
to 2.3 A˚ on the specimen. Images corresponding to T = 3
shells were selected interactively using Ximdisp (Smith,
1999) and then automatically boxed, floated, and normal-
ised in their grey value distribution. Particles from each
micrograph were processed as a group. Orientations and
origins of particles were determined by cross common lines
procedures, initially against the original T = 3 core map
without insert (Crowther et al., 1994). Once a map of the
particle with insert was available, this was used as reference
for determining orientations and origins. The map was
improved by inclusion of particles from additional micro-
graphs and by rounds of parameter refinement. The defocus
level of each micrograph was determined from the positions
of the zeros in the sum of squares of the transforms of the
particles. Correction for the contrast transfer function was
carried out by combining maps from micrographs at differ-
ent defocus as described (Bo¨ttcher and Crowther, 1996). It
quickly became clear that the degree of detail achievable
was limited by the disorder of the inserted region of protein.
Accordingly, the final map presented here was computed
using a total of 239 images (out of 300 initially selected)
from four micrographs at a Fourier cutoff of 21 A˚.
Endotoxin contamination of particles
Endotoxin contamination of purified core particles was
determined using the Limulus Amebocyte Lysate Pyrogent
Plus assay according to the protocol of the manufacturer
(BioWhittaker, Walkersville, MD).
Mice and immunisations
Female BALB/c (H-2d) and C57BL/6 (H-2b) mice were
obtained from the breeding colony of the Institute of
Microbiology and Virology, Riga, Latvia, and held at the
Biomedical Research and Study Centre in Riga. Four
BALB/c and three C57BL/6 mice were immunised with
HBcd, HBcdDOB120, HBcdHTN120, or HBcdPUU120.
On day 0, 20 Ag of proteins were given intraperitoneally
(half a dose) and subcutaneously (second half of dose) with
complete Freund’s adjuvant (CFA), 10 Ag of protein with
incomplete Freund’s adjuvant (IFA) on day 10, and 20 Ag of
protein in IFA on day 19. Blood was taken from each animal
by retroorbital bleeding at days 0 and 28.Antigens for characterisation of immune responses
The expression and purification of the recombinant
nucleocapsid (rN) proteins from hantaviruses DOBV, strain
Slovenia (DOBV-Slo) and strain Slovakia (DOBV-Slk),
HTNV, strain Fojnica (HTNV-Foj), and PUUV strains
Vranica/Ha¨llna¨s (PUUV-Vra), Kazan (PUUV-Kaz) and Sot-
kamo (PUUV-Sot) were performed as described earlier
(Dargeviciute et al., 2002; Razanskiene et al., submitted
for publication).
ELISA
The ELISA used for endpoint titration of mice sera
immunised with HBcdDOB120, HBcdHTN120, and
HBcdPUU120 was performed as recently described for
yeast-expressed rN protein (Geldmacher et al., 2004). Brief-
ly, coating was performed with 10 Ag/ml rN proteins of
DOBV-Slo, DOBV-Slk, HTN-Foj, PUUV-Vra, PUUV-Kaz,
or PUUV-Sot at 4 jC overnight. After blocking, serum was
titrated 3-fold on the plate starting with a serum dilution of
1:150. After the addition of horse radish peroxidase (HRP)-
labelled anti-mouse IgG (Sigma-Aldrich, Munich, Ger-
many), assays were developed with o-Phenylenediamine
(Sigma-Aldrich).
SDS-PAGE and Western Blot
Protein samples were separated by electrophoresis in
12.5% or 15% SDS polyacrylamide gels. Protein bands
were stained by Coomassie blue. For Western blot, proteins
were transferred to cellulose nitrate membrane by semidry
blotting. After transfer, cellulose membranes were blocked
with 5% dry milk/PBS containing 0.1% Tween (PBS/T) for
1 h and incubated overnight in PBS/T dilutions of the mAbs
1C12, 4C3, 5A3 (Lundkvist and Niklasson, 1992; Lundkv-
ist et al., 1991; diluted 1:1000 and 1:300, respectively), E5/
G6, Eco2 (Yoshimatsu et al., 1996; diluted 1: 1000), A1C5
or B5D9 (Zo¨ller et al., 1993; Progen Biotechnik, Heidel-
berg, Germany; diluted 1:1000), rabbit serum raised against
core/GFP particles (Kratz et al., 1999; diluted 1:5000), or
BALB/c mouse serum raised against yeast-expressed
DOBV-Slo rN protein (Geldmacher et al., 2004; diluted
1:2000). Thereafter, cellulose membranes were incubated
with HRP-labelled anti-mouse IgG (diluted 1:3000, Sigma-
Aldrich) or anti-rabbit IgG (diluted 1:3000, Sigma-Aldrich)
in PBS/T for 2 h. The peroxidase staining was performed by
adding 4-chloro-1-naphthol (Sigma-Aldrich) supplemented
with H2O2.
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